This accreditation, granted by the Ministry of Science, Innovation and Universities, recognizes the relevance and impact of IBEC’s research results internationally and entails funding of 4.5 million euros over 4 years.
Today, on March 14th, the joint ICMS-IBEC symposium took place. This event was co-organized by IBEC and the Institute for Complex Molecular Systems (ICMS). Throughout the conference, researchers from both IBEC and ICMS presented their areas of research, aiming to enhance the scientific collaboration between the two institutions.
Today, the event “Advances in Ataxia Telangiectasia” took place, organized by the Institute of Bioengineering of Catalonia (IBEC) in collaboration with AEFAT, the Spanish ataxia-telangiectasia family association. The gathering brought together patients’ families, researchers, and clinicians to explore the latest advancements in the clinical management of ataxia telangiectasia.
The project focuses on developing a chip that will serve as a model for testing new drugs to treat neuroblastoma, a childhood brain cancer. The research has received €200,000 in funding and is led by Aránzazu Villasante, Senior Researcher at IBEC.
Experts in nanomedicine from various fields have gathered today for the fifth consecutive year at Nano Rare Diseases Day. This event is co-organized by the NANOMED Spain platform, coordinated by IBEC, and SJD Barcelona Children’s Hospital, showcasing the latest advances in nanomedicine for the diagnosis and treatment of rare diseases.
From February 14 to 16, IBEC hosted 20 research managers from Widening countries. This initiative, promoted by the NCP_WIDERA.NET project, aims for these managers to acquire the best practices of centers of excellence to apply them in their own institutions and explore possible synergies.
Sergi Camacho Clavijo joins today as the new manager of the Institute for Bioengineering of Catalonia (IBEC), bringing with him almost 25 years of experience in managing entities in the field of health.
Today, on February 14, IBEC organized the roundtable “Challenges in Innovation in Personalized Medicine and Emerging Therapies.” The event is part of Barcelona Health Innovation Week, organized by Biocat. It fostered a dialogue where experts from diverse fields shared their perspectives on identifying opportunities to propel the utilization of new technologies in the healthcare sector.
Once again, experts in nanomedicine from various fields gathered in Barcelona on the occasion of World Cancer Day. The meeting provided an opportunity to showcase the latest innovations in nanomedicine for combating cancer, covering topics such as early diagnosis, controlled drug release, and radiotherapy employing nanoparticles.
IBEC kicks off 2024 with the incorporation of three new research groups led by Manuel Salmerón Sánchez, Zaida Álvarez Pinto, and Xavier Rovira Clavé. With these additions, IBEC strengthens its position in the field of advanced and emerging therapies.